R&D Strength

The company is the national high-tech enterprise with strong technical force, establishes with the academician workstation, the provincial postdoctoral workstation and the provincial R&D center, and owns two R&D subsidiaries located in Hangzhou, established the development platform and team for featured APIs and advanced pharmaceutical preparations, to create a technical service platform combined with biosynthesis, continuous flow chemistry, chiral drugs development and liposome formulations development.

The company has a professional R&D team consisting of doctors, masters and other educational levels, and the R&D personnel account for more than 20% of the total number of the company. Meanwhile, the company has the modern laboratory and GMP-compliance pilot workshop, equipped with advanced R&D instruments such as HPLC, GC, LC-MS, IR, UV and TOC, to complete systematic research of API and drug product projects from the lab scale test to the pilot scale test, and further to the commercial production, which provide sufficient guarantee for the development and industrialization of new products and new technologies.  

In addition to independent research and development, the company also maintains long-term good cooperation with well-known domestic universities and institutions such as Zhejiang University of Technology, Shenyang Pharmaceutical University, hires academicians and experts as enterprise consultants, giving full play to the interactive advantages of production, academy and research, to provide a strong technical support for the development of the company.

The company has always taken scientific and technological innovation as an important strategy for enterprise development, and constantly increased R&D investment and gradually enhanced innovation capability. In recent years, the company has undertaken several scientific and technological projects, including the National Key New-Product Plan, the National Torch Plan, Zhejiang Provincial Major Science and Technology Project, etc.